Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Address
1111 KANE CONCOURSE
BAY HARBOR ISLANDS, FL 33154
Founded
2006
Number of Employees
186
Website
http://www.fortressbiotech.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | $138 | - | - | - | - | $138 |
| Average Price | - | - | - | - | - | - | $30.00 | - | - | - | - | $30.00 |
| # Shares Purchased | - | - | - | - | - | - | 4,611 | - | - | - | - | 4,611 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | -96.7% | - | - | - | - | -96.7% |
| S&P 500 Return to Date | - | - | - | - | - | - | 74.8% | - | - | - | - | 74.8% |
| Excess Total Return | - | - | - | - | - | - | -171.5% | - | - | - | - | -171.5% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | 1% | - | - | - | - | 1% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
People also followed
Never miss an email alert when insiders at FBIO make a trade.
Creating a free account takes less than one minute